I appreciate Dr. Lange's kind words and agree with his conclusions. We cannot embrace a “no screening” policy. The ERSPC study has shown that screening can reduce prostate cancer mortality within 8 years of diagnosis.1 Furthermore, this benefit may increase as we follow patients for a longer duration. There are major differences however, in the way PSA testing is practiced in the United States and that described in the ERSPC study.The ERSPC analysis focused only on screening men between the ages...